Boundless Bio (BOLD) vs Zhengye Biotechnology (ZYBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Boundless Bio (BOLD) has outperformed Zhengye Biotechnology (ZYBT) over the past year, gaining 114.6% versus a loss of 60.5%. Boundless Bio is the larger company by market cap ($57.8 million vs $54.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BOLD | ZYBT |
|---|---|---|
| Share price | $2.54 | $1.15 |
| Market cap | $57.78M | $54.50M |
| 1-day change | -3.79% | -0.86% |
| YTD return | +120.00% | +0.87% |
| 1-year return | +114.63% | -60.54% |
| EPS (TTM) | $-2.85 | $-0.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.16 | $8.01 |
| 52-week low | $0.961 | $0.616 |
| Distance from 52-week high | -19.72% | -85.64% |
| Average volume | 179.14K | 5.11M |
| Shares outstanding | 22.75M | 47.39M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BOLD has outperformed ZYBT by 175.2 percentage points over the past year.
BOLD vs ZYBT FAQ
Which is bigger, Boundless Bio or Zhengye Biotechnology?
Boundless Bio (BOLD) is larger, with a market capitalization of $57.78M compared with $54.50M for Zhengye Biotechnology (ZYBT).
Which stock has performed better over the past year, BOLD or ZYBT?
BOLD returned +114.63% over the past 12 months, compared with -60.54% for ZYBT (price return, excluding dividends). Past performance does not predict future results.
Are Boundless Bio and Zhengye Biotechnology in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.